全文获取类型
收费全文 | 6059篇 |
免费 | 240篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 88篇 |
妇产科学 | 31篇 |
基础医学 | 703篇 |
口腔科学 | 154篇 |
临床医学 | 343篇 |
内科学 | 1672篇 |
皮肤病学 | 69篇 |
神经病学 | 339篇 |
特种医学 | 271篇 |
外科学 | 1056篇 |
综合类 | 28篇 |
预防医学 | 216篇 |
眼科学 | 161篇 |
药学 | 389篇 |
中国医学 | 12篇 |
肿瘤学 | 729篇 |
出版年
2023年 | 40篇 |
2022年 | 105篇 |
2021年 | 169篇 |
2020年 | 73篇 |
2019年 | 91篇 |
2018年 | 127篇 |
2017年 | 90篇 |
2016年 | 133篇 |
2015年 | 127篇 |
2014年 | 188篇 |
2013年 | 245篇 |
2012年 | 392篇 |
2011年 | 380篇 |
2010年 | 220篇 |
2009年 | 173篇 |
2008年 | 322篇 |
2007年 | 401篇 |
2006年 | 339篇 |
2005年 | 341篇 |
2004年 | 390篇 |
2003年 | 359篇 |
2002年 | 357篇 |
2001年 | 98篇 |
2000年 | 109篇 |
1999年 | 94篇 |
1998年 | 81篇 |
1997年 | 77篇 |
1996年 | 61篇 |
1995年 | 49篇 |
1994年 | 41篇 |
1993年 | 43篇 |
1992年 | 66篇 |
1991年 | 53篇 |
1990年 | 47篇 |
1989年 | 43篇 |
1988年 | 49篇 |
1987年 | 68篇 |
1986年 | 44篇 |
1985年 | 56篇 |
1984年 | 40篇 |
1983年 | 16篇 |
1982年 | 18篇 |
1981年 | 12篇 |
1980年 | 12篇 |
1979年 | 19篇 |
1978年 | 10篇 |
1977年 | 13篇 |
1976年 | 14篇 |
1975年 | 5篇 |
1967年 | 4篇 |
排序方式: 共有6325条查询结果,搜索用时 15 毫秒
81.
82.
Sherri Dudal Daniel Baltrukonis Rebecca Crisino M. Jaya Goyal Alison Joyce Karolina Österlund John Smeraglia Yoshitaka Taniguchi Jihong Yang 《The AAPS journal》2014,16(2):194-205
As part of the GBC (Global Bioanalysis Consortium), the L3 assay format team has focused on reviewing common platforms used to support ligand binding assays in the detection of biotherapeutics. The following review is an overview of discussions and presentations from around the globe with a group of experts from different companies to allow an international harmonization of common practices and suggestions for different platforms. Some of the major platforms include Gyrolab, Erenna, RIA, AlphaLISA, Delfia, Immuno-PCR, Luminex, BIAcore, and ELISAs. The review is meant to support bioanalysts in taking decisions between different platforms depending on the needs of the analyte with a number of recommendations to help integration of platforms into a GLP environment. 相似文献
83.
Takashi Uchiyama Hirokazu Takahashi Hiroki Endo Shingo Kato Eiji Sakai Kunihiro Hosono Masato Yoneda Masahiko Inamori Yoshitaka Hippo Hitoshi Nakagama Atsushi Nakajima 《Digestive endoscopy》2012,24(5):353-357
Aim: Endoscopic screening and removal of colorectal adenomas can reduce the incidence of colorectal cancer. However, given the possibility of adenoma recurrence, surveillance colonoscopy is currently recommended after the initial screening and removal of colorectal adenomas. Aberrant crypt foci (ACF) have been shown to serve as a reliable surrogate marker of colorectal carcinogenesis. In this study, the relationship between the number of ACF at the initial endoscopic polypectomy and the likelihood of colorectal adenoma recurrence after polypectomy were investigated. Methods: High‐magnification chromoscopic colonoscopy was performed in 82 subjects who underwent endoscopic polypectomy to identify ACF in the lower rectum. Surveillance colonoscopy was then performed 3 years after the baseline polypectomy at Yokohama City University Hospital. Results: The number of ACF was greater in patients who showed adenoma recurrence (7.88 ± 6.35) than in those who did not (2.19 ± 2.95) (P < 0.001). Receiver–operating curve analysis showed that the number of ACF was a highly specific predictor of the risk of adenoma recurrence. Conclusions: This is the first study conducted to investigate the relationship between the number of ACF after endoscopic polypectomy and the likelihood of recurrence of colorectal adenomas. These results suggest that the number of ACF is a useful predictor of the likelihood of colorectal adenoma recurrence. 相似文献
84.
85.
86.
87.
Yozo Sato Yoshitaka Inaba Hidekazu Yamaura Haruyuki Takaki Yasuaki Arai 《Journal of vascular and interventional radiology : JVIR》2012,23(10):1377-1380
A 65-year-old woman with liver metastases from colon cancer and tumor thrombus extending from the right hepatic vein (HV) to the right atrium (RA) presented with marked lower-extremity edema and massive ascites. Computed tomography showed tumor thrombus completely occluding the inferior vena cava (IVC) and HV ostia. Recanalization of the IVC and HVs was performed. Metallic stents were placed in tandem from the superior vena cava to the IVC through the RA, and additional metallic stents were placed in the left HV. The patient's symptoms were relieved, and there was no recurrence of these symptoms for 19.5 months until death. 相似文献
88.
Hiyama T Tanaka S Yoshihara M Sasao S Kose K Shima H Tuncel H Ueno Y Ito M Kitadai Y Yasui W Haruma K Chayama K 《Journal of gastroenterology and hepatology》2004,19(7):756-760
BACKGROUND: Gastric cancer can progress through two pathways of genomic instability: chromosomal (CIN) and microsatellite instability (MSI). It is hypothesized that these two pathways are not always independent and that some tumors show overlap between these two mechanisms. METHODS: A total of 98 sporadic gastric cancers were classified based on their MSI status, using microsatellite assay with BAT26. Evidence for CIN was investigated by identifying loss of heterozygosity (LOH) events on chromosome arms, 5q, 10p, 17p, 17q, and 18q, which are regions harboring tumor suppressor genes that are significant in gastric cancer development. RESULTS: Twelve tumors (12%) showed high-frequency MSI (MSI-H). Overall, 43 of the tumors (44%) had at least one LOH event, with most frequent chromosomal losses observed on 10p and 18q (30%, respectively), followed by 5q (21%), 17p (14%), and 17q (12%). Interestingly, overlap was observed between CIN and MSI pathways. Of 43 cancers with LOH events, four (9%) were also MSI-H. It was also found that 48% of cancers without MSI-H had no LOH events identified, comprising a subgroup of tumors that were not representative of either of these two pathways of genomic instability. CONCLUSION: These results suggest that molecular mechanisms of genomic instability are not necessarily independent and may not be fully defined by either the MSI or CIN pathways in sporadic gastric cancers. 相似文献
89.
Hideki Ohkubo MD Hirotaka Musha MD Dr. Kunio Okuda MD 《Digestive diseases and sciences》1978,23(11):1017-1024
The effect of caloric restriction on the hepatic uptake and excretion of indocyanine green (ICG) was studied in man as well as in rats. It was demonstrated that following a 72-hr caloric restriction in man, the plasma clearance rate for ICG was increased significantly at the low dose of 0.5 mg/kg, and transport maximum was increased without a significant change of storage capacity. In rats, the maximal biliary excretion was significantly increased after 48-hr fast, but neither maximal hepatic uptake (V
max) nor hepatic ICG content was altered. The evidence is consistent with the view that fasting increases the ICG plasma clearance at low doses by enhancement of excretory steps at the bile canalicular membrane. 相似文献
90.
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients 总被引:1,自引:0,他引:1
Wada H Mori Y Okabayashi K Gabazza EC Kushiya F Watanabe M Nishikawa M Shiku H Nobori T 《American journal of hematology》2003,72(1):1-7
We measured the plasma level of fibrinogen in 560 patients with disseminated intravascular coagulation (DIC) and evaluated its relationship with outcome and with other hemostatic markers. Forty-seven percent of patients had >200 mg/dL of plasma fibrinogen and 24% had <100 mg/dl of plasma fibrinogen, suggesting that plasma fibrinogen level is not a sensitive marker for DIC. In our analysis of outcome and plasma fibrinogen levels, the rate of death was high in leukemia/lymphoma patients with high fibrinogen concentration, but no significant difference in outcome was observed in relation to plasma fibrinogen concentration in non-leukemia/lymphoma patients with DIC. Among patients with leukemia/lymphoma, the frequency of organ failure was markedly high in patients with high plasma levels of fibrinogen. Among patients without leukemia/lymphoma, the frequency of organ failure increased concomitantly with the increase in plasma fibrinogen levels. The international normalized ratio was significantly increased in leukemia/lymphoma patients with low fibrinogen. FDP levels were slightly increased in patients with low fibrinogen. Platelet count was significantly low in patients without leukemia/lymphoma with high fibrinogen. DIC score increased concomitantly with the reduction in plasma fibrinogen levels. Plasma levels of thrombomodulin and tissue factor were significantly high in patients with high fibrinogen levels. Plasma levels of antiplasmin and plasminogen were significantly decreased in patients with low fibrinogen. Plasma levels of plasmin plasmin-inhibitor complex and tissue type plasminogen activator/plasminogen activator inhibitor-1 complex (PAI-I) were significantly higher in patients with low fibrinogen than in those with high fibrinogen. Plasma levels of PAI-I and IL-6 were significantly higher in patients with high fibrinogen than in those with low fibrinogen. Patients with high fibrinogen levels showed less activation of secondary fibrinolysis, which might explain the occurrence of organ failure and poor outcome. 相似文献